Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group

Herishanu, Yair ; Shaulov, Adir ; Fineman, Riva ; Bašić‐Kinda, Sandra ; Aviv, Ariel ; Wasik‐Szczepanek, Ewa ; Jaksic, Ozren ; Zdrenghea, Mihnea ; Greenbaum, Uri ; Mandac, Inga ; Simkovic, Martin ; Morawska, Marta ; Benjamini, Ohad ; Spacek, Martin ; Nemets, Anatoly ; Bairey, Osnat ; Trentin, Livio ; Ruchlemer, Rosa ; Laurenti, Luca ; Stanca Ciocan, Oana ; Doubek, Michael ; Shvidel, Lev ; Dali, Nagib ; Mirás, Fátima ; De Meûter, Anne ; Dimou, Maria ; Mauro, Francesca R. ; Coscia, Marta ; Bumbea, Horia ; Szász, Róbert ; Tadmor, Tamar ; Gutwein, Odit ; Gentile, Massimo ; Scarfò, Lydia ; Tedeschi, Alessandra ; Sportoletti, Paolo ; Gimeno Vázquez, Eva ; Marquet, Juan ; Assouline, Sarit ; Papaioannou, Maria ; Braester, Andrei ; Levato, Luciano ; Gregor, Michael ; Rigolin, Gian M. ; Loscertales, Javier ; Medina Perez, Angeles ; Nijziel, Marten R. ; Popov, Viola M. ; Collado, Rosa ; Slavutsky, Irma ; Itchaki, Gilad ; Ringelstein, Shimrit ; Goldschmidt, Neta ; Perry, Chava ; Levi, Shai ; Polliack, Aaron ; Ghia, Paolo

American journal of hematology, 2020-06, Vol.95 (6), p.604-611 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível